curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page
Parents’ grief after Ender Nihat’s clinical trial death

Parents’ grief after Ender Nihat’s clinical trial death

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment.  A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment. 
Clinical Trials Market | Trends, Growth, Size & Forecast 2024-2031 | Syneos Health, Inc., WuXi AppTec Co., Ltd, Celerion.

Clinical Trials Market | Trends, Growth, Size & Forecast 2024-2031 | Syneos Health, Inc., WuXi AppTec Co., Ltd, Celerion.

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  The Global Clinical Trials Market reached USD 56 640 7 million in 2022 and is projected to witness lucrative growth by reaching up to USD 99 212 0 million by 2031 The clinical trials market is expected to exhibit a …  The Global Clinical Trials Market reached...
Researchers discover race-associated molecular differences in pancreatic tumors

Researchers discover race-associated molecular differences in pancreatic tumors

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies.  Researchers have discovered race-associated molecular differences in tumors that may impact the way...
China Medical University Hospital Joins With AbbVie to Promote Innovative Clinical Trial Collaboration

China Medical University Hospital Joins With AbbVie to Promote Innovative Clinical Trial Collaboration

by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials

​  Li-Yuan Bai, M.D., M.M.S., Ph.D.  Li-Yuan Bai, M.D., M.M.S., Ph.D. 
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy

GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​  /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for…  /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced...

Research on the Improvement of Intestinal and Immune Functions by Probiotics

by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials

​ Conditions: Intestinal Health Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo Sponsors: Wecare Probiotics Co., Ltd. Not yet recruiting Conditions: Intestinal Health Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo...
« Older Entries
Next Entries »

Recent Posts

  • Evaluation of Postoperative Pain After Using Resin-Based and Bioceramic Sealers in Mandibular Molars With Asymptomatic Apical Periodontitis
  • Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:
  • Hydrodissection With Neuroprolotherapy Versus Open Release for Carpal Tunnel Syndrome
  • Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
  • Myofascial Release and Dynamic Cupping in Children

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®